Cargando…

MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019

METHODS Study: Analytical and retrospective Patients files diagnosed with Thyroid Cancer treated during January 2010 to May 2019, who underwent surgical intervention and histopathological study were reviewed. Chi Square test were used as statistical analysis. A level of significance p <0.001 was...

Descripción completa

Detalles Bibliográficos
Autores principales: Galán, Isabel B, Barreto, Thelma G, Reyes, Lucia, Calzada, Raùl, Arguinzoniz, Lissette, Ruiz, Maria de la Luz, Altamirano, Nelly, Diaz, Luisa G, Bonilla, Paola Sophia, Robles, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207728/
http://dx.doi.org/10.1210/jendso/bvaa046.1284
_version_ 1783530673164779520
author Galán, Isabel B
Barreto, Thelma G
Reyes, Lucia
Calzada, Raùl
Arguinzoniz, Lissette
Ruiz, Maria de la Luz
Altamirano, Nelly
Diaz, Luisa G
Bonilla, Paola Sophia
Robles, Carlos
author_facet Galán, Isabel B
Barreto, Thelma G
Reyes, Lucia
Calzada, Raùl
Arguinzoniz, Lissette
Ruiz, Maria de la Luz
Altamirano, Nelly
Diaz, Luisa G
Bonilla, Paola Sophia
Robles, Carlos
author_sort Galán, Isabel B
collection PubMed
description METHODS Study: Analytical and retrospective Patients files diagnosed with Thyroid Cancer treated during January 2010 to May 2019, who underwent surgical intervention and histopathological study were reviewed. Chi Square test were used as statistical analysis. A level of significance p <0.001 was established. INTRODUCTION: Cancer thyroid in pediatrics is characterized by advanced presentation, coupled with frequent lymph nodal metastases and often pulmonary metastases. There are few reports on the rate of cancer and hypoparathyroidism in children. OBJECTIVE: Describe of pediatric thyroid cancer with particular emphasis on the clinical characteristics, risk factors associated and with treatment outcomes RESULTS 43 patients were included in the study 69.8% were female. Average age of 12 years (range 5 to 17 years). Association of cancer and thyroiditis 25% and Cancer with Graves Disease 2.3%. Histopathological diagnoses of thyroid cancer: 86% papillary, 2.3% follicular, 11.6% medullary, 69.8% patients presented with metastases, most often lymph node (46.5%), pulmonary (2.3%) and pulmonary plus lymph node (23.3%), 11.6% patients do not present metastasis and 16.3% without data. Surgical interventions: only thyroidectomy 16.3%, Hemitiroidectomy 4.7%, total thyroidectomy with lymph node emptying 74% and modified radical neck dissection 5%.In 16% of the patients, second surgery was required after the histopathological report. Post-surgical hypoparathyroidism was recorded in 27 patients (62%): transitory in 11 (25%) and 16 (37%) permanent. Biochemical variables: (N /%/ Hypoparathyroidism /NO hypoparathyroidism) of 18 patients with post-surgical PTH <10 pg/ml (18/42%/17/1) 17 of them presented post-surgical hypoparathyroidism (P <0.001), PTH >10 pg/ml (13/30%/9/4), and without post-surgical measurement of PTH (12/28% / 6/6). Post-surgical ionized calcium <4mg/dl in 29 patients of which 22 had hypoparathyroidism (P <0.001) (29 / 67.4% / 22/7), with calcium >4 mg/dL (14 / 32.6% / 9/5). 21 patients with seric calcium <8mg/dl 20 with hypoparathyroidism. (21/48%/ 20/1) (P <0.001). Seric calcium >8 (16/37%/9/7) without measurement data. Serial calcium in 6 patients (6/15% / 3/3). Postoperative positive thyroglobulin parameter was presented as an risk factor for complication and metastases OR 1.42 (1-1.6) Regarding iodine treatment, 29 patients received an average dose of 200 (range 100- 720 milicuries mCi). CONCLUSIONS Papillary cancer is the most common type in pediatric patients, evidence of metastases find in 69.8% most frequent lymph node, postoperative thyroglobulin OR 1.42. They should always be considered in the management of these patients. As a post-surgical complication, there is an increased risk to present hypoparathyroidism when PTH less < 10 pg / ml, post-surgical ionized calcium < 4 mg/dl and serum calcium <8 mg/dl.
format Online
Article
Text
id pubmed-7207728
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72077282020-05-13 MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019 Galán, Isabel B Barreto, Thelma G Reyes, Lucia Calzada, Raùl Arguinzoniz, Lissette Ruiz, Maria de la Luz Altamirano, Nelly Diaz, Luisa G Bonilla, Paola Sophia Robles, Carlos J Endocr Soc Pediatric Endocrinology METHODS Study: Analytical and retrospective Patients files diagnosed with Thyroid Cancer treated during January 2010 to May 2019, who underwent surgical intervention and histopathological study were reviewed. Chi Square test were used as statistical analysis. A level of significance p <0.001 was established. INTRODUCTION: Cancer thyroid in pediatrics is characterized by advanced presentation, coupled with frequent lymph nodal metastases and often pulmonary metastases. There are few reports on the rate of cancer and hypoparathyroidism in children. OBJECTIVE: Describe of pediatric thyroid cancer with particular emphasis on the clinical characteristics, risk factors associated and with treatment outcomes RESULTS 43 patients were included in the study 69.8% were female. Average age of 12 years (range 5 to 17 years). Association of cancer and thyroiditis 25% and Cancer with Graves Disease 2.3%. Histopathological diagnoses of thyroid cancer: 86% papillary, 2.3% follicular, 11.6% medullary, 69.8% patients presented with metastases, most often lymph node (46.5%), pulmonary (2.3%) and pulmonary plus lymph node (23.3%), 11.6% patients do not present metastasis and 16.3% without data. Surgical interventions: only thyroidectomy 16.3%, Hemitiroidectomy 4.7%, total thyroidectomy with lymph node emptying 74% and modified radical neck dissection 5%.In 16% of the patients, second surgery was required after the histopathological report. Post-surgical hypoparathyroidism was recorded in 27 patients (62%): transitory in 11 (25%) and 16 (37%) permanent. Biochemical variables: (N /%/ Hypoparathyroidism /NO hypoparathyroidism) of 18 patients with post-surgical PTH <10 pg/ml (18/42%/17/1) 17 of them presented post-surgical hypoparathyroidism (P <0.001), PTH >10 pg/ml (13/30%/9/4), and without post-surgical measurement of PTH (12/28% / 6/6). Post-surgical ionized calcium <4mg/dl in 29 patients of which 22 had hypoparathyroidism (P <0.001) (29 / 67.4% / 22/7), with calcium >4 mg/dL (14 / 32.6% / 9/5). 21 patients with seric calcium <8mg/dl 20 with hypoparathyroidism. (21/48%/ 20/1) (P <0.001). Seric calcium >8 (16/37%/9/7) without measurement data. Serial calcium in 6 patients (6/15% / 3/3). Postoperative positive thyroglobulin parameter was presented as an risk factor for complication and metastases OR 1.42 (1-1.6) Regarding iodine treatment, 29 patients received an average dose of 200 (range 100- 720 milicuries mCi). CONCLUSIONS Papillary cancer is the most common type in pediatric patients, evidence of metastases find in 69.8% most frequent lymph node, postoperative thyroglobulin OR 1.42. They should always be considered in the management of these patients. As a post-surgical complication, there is an increased risk to present hypoparathyroidism when PTH less < 10 pg / ml, post-surgical ionized calcium < 4 mg/dl and serum calcium <8 mg/dl. Oxford University Press 2020-05-08 /pmc/articles/PMC7207728/ http://dx.doi.org/10.1210/jendso/bvaa046.1284 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Galán, Isabel B
Barreto, Thelma G
Reyes, Lucia
Calzada, Raùl
Arguinzoniz, Lissette
Ruiz, Maria de la Luz
Altamirano, Nelly
Diaz, Luisa G
Bonilla, Paola Sophia
Robles, Carlos
MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title_full MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title_fullStr MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title_full_unstemmed MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title_short MON-092 Clinical Characteristics and Management of Thyroid Cancer in Pediatrics: Results from the Mexican Population Registry Between 2010-2019
title_sort mon-092 clinical characteristics and management of thyroid cancer in pediatrics: results from the mexican population registry between 2010-2019
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207728/
http://dx.doi.org/10.1210/jendso/bvaa046.1284
work_keys_str_mv AT galanisabelb mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT barretothelmag mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT reyeslucia mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT calzadaraul mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT arguinzonizlissette mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT ruizmariadelaluz mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT altamiranonelly mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT diazluisag mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT bonillapaolasophia mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019
AT roblescarlos mon092clinicalcharacteristicsandmanagementofthyroidcancerinpediatricsresultsfromthemexicanpopulationregistrybetween20102019